Clinically Relevant Anti-Epileptic Drug Interactions
- 1 January 1990
- journal article
- review article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 18 (1), 1-15
- https://doi.org/10.1177/030006059001800102
Abstract
Anti-epileptic drugs frequently interact due to pharmacokinetic features (induction or inhibition of metabolism, production of active metabolites, low therapeutic indices) and the need for prolonged treatment with possible addition of other drugs to treat concomitant diseases. The most important pharmacokinetic interactions are those that inhibit phenytoin, carbamazepine and phenobarbitone metabolism and thus increase their toxicity. Drugs inhibiting metabolism include antibiotic macrolides, chloramphenicol, isoniazide, some sulphonamides, propoxyphene, cimetidine, valproic acid and sulthiame. Anti-epileptic drugs can induce hepatic microsomal enzymes and, therefore, may increase metabolism of corticosteroids, oral contraceptives, oral anticoagulants, cardiovascular agents, antibiotics, chemotherapeutic agents, psychotropic drugs and non-opiate analgesics, thereby reducing their efficacy. Advantageous pharmacodynamic interactions include synergism of ethosuximide plus valproic acid and of carbamazepine plus valproic acid. A pharmacodynamic mechanism may be responsible for the reduced sensitivity of chronically treated epileptics to some neuromuscular blockers.Keywords
This publication has 92 references indexed in Scilit:
- Metronidazole Impairs Clearance of Phenytoin but Not of Alprazolam or LorazepamThe Journal of Clinical Pharmacology, 1988
- Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugsPharmacology & Therapeutics, 1987
- The Effect of Phenytoin on the Magnitude and Duration of Neuromuscular Block Following Atracurium or VecuroniumAnesthesiology, 1987
- Carbamazepine-Danazol Drug InteractionTherapeutic Drug Monitoring, 1986
- The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in childrenThe Journal of Pediatrics, 1982
- Kinetics of phenobarbital in normal subjects and epileptic patientsEuropean Journal of Clinical Pharmacology, 1982
- Albumin‐Binding Interactions of Sodium ValproateThe Journal of Clinical Pharmacology, 1980
- The Effect of Different Oral Anticoagulants on Diphenylhydantoin (DPH) and Tolbutamide MetabolismActa Medica Scandinavica, 1976
- Increased Rate of Clearance of Drugs from the Circulation of Alcoholics*The American Journal of the Medical Sciences, 1969
- DICOUMAROL-INDUCED DIPHENYLHYDANTOIN INTOXICATIONThe Lancet, 1966